These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15936601)

  • 1. Resistance to antiplatelet resistance is it justified?
    Steinhubl SR; Charnigo R; Moliterno DJ
    J Am Coll Cardiol; 2005 Jun; 45(11):1757-8. PubMed ID: 15936601
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposal of a "gradient model" to evaluate residual platelet activity on antiplatelet therapy: A pilot study.
    Lelli N; Rizkallah R; Ferrari P; Pedretti S; Cariani E; Trenti T
    Thromb Res; 2017 Feb; 150():19-21. PubMed ID: 27992784
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
    Mani H; Lindhoff-Last E
    Pharm Unserer Zeit; 2009; 38(4):342-50. PubMed ID: 19572355
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S; Gupta MM
    Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monitoring of antiplatelet drug effects--fashion or necessity?].
    Kuliczkowski W; Zembala M; Poloński L; Kaczmarski J; Gasior M
    Kardiol Pol; 2008 Jan; 66(1):119-24. PubMed ID: 18266199
    [No Abstract]   [Full Text] [Related]  

  • 6. Do the Behring Coagulation Timer and the Platelet Function Analyzer-100 identify the same patients as being aspirin non-responders?
    Mortensen J; Poulsen TS; Refsgaard J; Kristensen SD
    Platelets; 2007 Aug; 18(5):389-90; author reply 391-2. PubMed ID: 17654310
    [No Abstract]   [Full Text] [Related]  

  • 7. Response variability and the role of platelet function testing.
    Gurbel PA; Mahla E; Antonino MJ; Tantry US
    J Invasive Cardiol; 2009 Apr; 21(4):172-8. PubMed ID: 19342756
    [No Abstract]   [Full Text] [Related]  

  • 8. More on: enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized cross-over trial.
    Almsherqi ZA; McLachlan CS; Sharef SM
    J Thromb Haemost; 2006 Jul; 4(7):1638-9; author reply 1639-40. PubMed ID: 16839373
    [No Abstract]   [Full Text] [Related]  

  • 9. Durability of platelet inhibition by clopidogrel.
    Gurbel PA; Bliden KP
    Am J Cardiol; 2003 May; 91(9):1123-5. PubMed ID: 12714161
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.
    Mazur P; Frołow M; Niżankowski R; Sadowski J; Undas A
    Platelets; 2013; 24(2):151-5. PubMed ID: 22497730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.
    Armstrong PC; Dhanji AR; Truss NJ; Zain ZN; Tucker AT; Mitchell JA; Warner TD
    Thromb Haemost; 2009 Oct; 102(4):772-8. PubMed ID: 19806265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function and pharmacologic inhibition.
    Chaer RA; Graham JA; Mureebe L
    Vasc Endovascular Surg; 2006; 40(4):261-7. PubMed ID: 16959718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel.
    Sibbing D; von Beckerath O; Schömig A; Kastrati A; von Beckerath N
    J Thromb Haemost; 2006 Dec; 4(12):2566-8. PubMed ID: 16938125
    [No Abstract]   [Full Text] [Related]  

  • 14. Triple antiplatelet therapy for clopidogrel resistance with stent malapposition: a case report.
    Ding FH; Zhang Q; Zhang RY; Hu J; Shen J; Zhao LP; DU R; Zhang X; Shen WF
    Chin Med J (Engl); 2009 Sep; 122(18):2186-8. PubMed ID: 19781309
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study.
    Ajzenberg N; Aubry P; Huisse MG; Cachier A; El Amara W; Feldman LJ; Himbert D; Baruch D; Guillin MC; Steg PG
    J Am Coll Cardiol; 2005 Jun; 45(11):1753-6. PubMed ID: 15936600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
    Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
    Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet resistance to antiplatelet drugs.
    Kumar A; Kao J
    Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):98-108. PubMed ID: 19519552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study.
    De Luca G; Secco GG; Iorio S; Verdoia M; Bellomo G; Marino P
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):756-9. PubMed ID: 23135381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet reactivity and nonresponse to dual antiplatelet therapy: a review.
    Vila PM; Zafar MU; Badimon JJ
    Platelets; 2009 Dec; 20(8):531-8. PubMed ID: 19845440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.